Valmark Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
CS
Valmark Advisers's XBI Position: Q3 2015 in Review
Valmark Advisers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2015, closing a stake of 2,973 shares — an estimated $250K sold.
Valmark Advisers first reported a position in XBI in Q2 2015 and held it in 1 quarter. The position peaked at $250K in Q2 2015. 196 funds tracked by Wall St. Rank hold XBI as of Q3 2015.
- Valmark Advisers reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2015 after selling out during the quarter.
- Valmark Advisers sold 2,973 State Street SPDR S&P Biotech ETF shares in Q3 2015, an estimated $250K.
- Valmark Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 1 quarter.
- Valmark Advisers's State Street SPDR S&P Biotech ETF position peaked at $250K in Q2 2015.
- 196 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2015.
Based on Valmark Advisers's 13F filing for Q3 2015, filed 10 Nov 2015.